Results 221 to 230 of about 9,926 (263)
Some of the next articles are maybe not open access.
ENZYMATIC DECARBOXYLATION OF 2,6- AND 2,3-DIHYDROXYPHENYLALANINE
Canadian Journal of Biochemistry and Physiology, 1954The action of dihydroxyphenylalanine (dopa) decarboxylase of guinea pig kidney and of tyrosine decarboxylase of Streptococcus faecalis R on 2,3- and 2,6-dopa has been studied. Compared with 3,4-dopa, these substrates are decarboxylated by the kidney enzyme at rates decreasing in the order: 2,3-, 3,4-, 2,6-dopa.
openaire +2 more sources
The action of L‐dihydroxyphenylalanine in patients receiving nialamide
Clinical Pharmacology & Therapeutics, 1965Nialamide produces effective monamine oxidase inhibition resulting in a three‐ to fivefold increase in tryptamine excretion when administered in a dose of 100 mg. for 10 days. L‐Dihydroxyphenylalanine, given in a dose of 75 to 100 mg. to normal volunteers receiving nialamide in a dose of 100 mg.
D G, FRIEND, W R, BELL, N S, KLINE
openaire +2 more sources
Stability of collagen in the presence of 3,4-dihydroxyphenylalanine (DOPA)
Journal of Photochemistry and Photobiology B: Biology, 2009Many cross-linking agents for collagen are available with varying levels of toxicity and some are in use in biomedical implants of collagen. L-DOPA (3,4-dihydroxyphenylalanine), a neurotransmitter, is a naturally present compound in the living system and is the target in therapeutic strategy of Parkinson's disease.
R, Usha, A, Rajaram, T, Ramasami
openaire +2 more sources
ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS.
Canadian Medical Association journal, 1996Dihydroxyphenylalanine (dopa), the metabolic precursor of dopamine, was administered to 10 parkinsonian patients in oral doses of 1-5 g. and intravenous doses of 0.2-0.5 g. Increases in dopamine excretion of 100- to 1000-fold following the dopa administration indicated that dopa was being absorbed and metabolized. Only two of the 10 patients showed any
P L, MCGEER, L R, ZELDOWICZ
openaire +1 more source
Excretion of 3,4-dihydroxyphenylalanine in urine
Biochimica et Biophysica Acta (BBA) - General Subjects, 1961T, GERRITSEN, S C, COPPS, H A, WAISMAN
openaire +2 more sources
Remission in dihydroxyphenylalanine‐responsive dystonia
Movement Disorders, 1995M, Di Capua, E, Bertini
openaire +2 more sources
Microbiological synthesis of L-3,4-dihydroxyphenylalanine
Journal of the American Chemical Society, 1969C J, Sih +3 more
openaire +2 more sources

